By Gagan Dhawan,

The Kovid-19 epidemic has changed us in many ways. Lockdown restrictions and unintended changes from home culture to work have overturned our daily routines, activity levels, eating habits and sleep patterns. Several studies have reported that these lifestyle changes have resulted in weight gain / obesity in young people. With offices, schools, colleges, shops, etc. closing, people spend too much time on TVs, computers, and smartphones, resulting in very little physical activity. Also, taking extra high-calorie snacks and lack of access to healthy foods leads to more lifestyle risks and obesity.

Such weight gain has increased the chances of getting various diseases. Without resorting to quick fixes, we can choose the right way to get back to a healthy lifestyle. The epidemic has taught us the most important life lesson that our health is the most important. Without thinking about losing weight in a month, experts suggest choosing a healthy lifestyle that helps us lose weight and maintain it for a lifetime. In case of any confusion, here is a brief description of how a healthy lifestyle eliminates the root cause of the problem – obesity.

Stress management

As we all know, the most important problem faced by every person during lockdown was stress. Stress releases a type of hormone called cortisol, which leads to stress eating or unhealthy eating. This type of poor diet is mainly responsible for weight gain.

As a first step towards a healthier lifestyle, we must engage ourselves in activities of our choice, such as swimming, listening to music, painting, reading, playing games, and so on. In addition, we can practice deep breathing techniques that can help. We feel relaxed and positive. In addition, it is advisable to discuss the issues with family and friends as it relieves most of the stress.

Understanding our metabolism

Metabolism is the complex process by which our body converts food into energy. So, if we want to get rid of these extra kilos, we should focus on improving our metabolism rate because active metabolism leads to a healthy body. By understanding metabolism and how it burns energy, we can increase our total daily energy expenditure (TDEE) by increasing non-exercise activity thermogenesis (NEAT) in our routine.

Eat with the mind

Eating with the mind means eating slowly without confusion, knowing the difference between true hunger and non-hunger triggers, quantity control, and so on. This improves digestion and eliminates the tendency to overeat. With careful eating habits, we should switch our food choices to the following 5 principles:

1. Animal to plant based food
2. From extra processed grains to whole grains
3. From fried and overcooked to steaming, roasting and hunting.
4. From all cooked foods up to 50% fresh and raw foods
5. From chemical / pesticide-based foods to organic foods.

Incorporate exercise routines

Just as plants cannot survive in sunlight, so our bodies cannot survive on food alone. In addition to a healthy plant-based diet, we must include exercise routines in our daily lives. Regular exercise helps to significantly increase our metabolism and immune system. It promotes weight management and secretes happy hormones like serotonin and endorphins which relieve stress and keep us extremely strong throughout the day. Witnessing the common COVID-infected situation where the gym is opening and closing due to restrictions, adding bodyweight exercises to our workout routine without relying on the gym may be a more consistent plan.

Drink enough water

Surprisingly, water helps us burn more calories. Yes! You heard it right. Sometimes we confuse hunger with thirst and tend to overeat. So, we must drink at least 3-4 liters of water per day as it is a natural appetite suppressant which reduces hunger and provides a feeling of fullness. Also, drinking water helps in weight loss by removing body wastes.

Getting quality sleep

We spent the lockdown period mostly watching TV and foolishly surfing the internet all night, compromising our sleep. Lack of sleep has significantly increased stress levels and reduced our metabolism, resulting in weight gain. So, for a healthy lifestyle, we must try to get at least 6-8 hours of adequate sleep. Since our body heals between 10pm and 4am, following the good old golden rule, it can be really helpful at this time to go to bed early and get up early.

The importance of continuity

Continuity is undoubtedly the key to a healthy lifestyle. This helps us to achieve our weight loss goals slowly and steadily and maintain the same. The key to staying consistent with our goals is to enjoy our journey. So, starting with a small habit that we can adapt to may be our first child’s step towards a healthier lifestyle.

Inspirational tweaks

We must write our routine in a daily journal. This habit records our body measurements to compare changes and reward ourselves for each achievement. Always remember that inspiration can fade, but it is our self-discipline that keeps us ahead.

The last row

When people gradually introduce these mentioned health changes into their lives, they no longer find themselves critical of dealing with epidemic-driven obesity problems. These healthy practices help us to get rid of all the negative thoughts and emotions that affect our mental health. After all, a healthy lifestyle is synonymous with an active body and mind that helps us to improve as we spend each day.

(The author is the founder and CEO, The New Me. The article is for informational purposes only. Please consult with medical professionals and health professionals before starting any therapy, medication and / or remedies. .com policy.)

Snapping the two-day winning trend, the domestic equity market closed with a slight loss in profit booking on Wednesday. The broader Nity50 and Sensex fell 0.12% and 0.20%, respectively, as the 50-share index closed below 16,250 and the latter closed near 54,200. Following the benchmark, the Nifty Mid Cap and Small Cap closed down 0.2% and 0.4%, respectively.

Meanwhile, FMCG, pharma and healthcare rose 1.25% as they prevented the market from slipping further. In addition to these sectors, all Nifty sectoral indices closed in red with the biggest hit of Realty and PSU Bank.

“In support of pharma and FMCG stocks, there was a steady race in the domestic market until the weak opening in the European market. Services Research 8

With interest rates likely to rise by global central banks, investors are advised that the sectors are least affected by protectionist policies, Nair suggests.

According to Gaurab Ratnaparkhi, Head of Technical Research, Sharekhan, BNP Paribas, the short-term pull was still intact and the Nifty could attract interest buying near 16,200.

“The Nifty opened on a positive note and tried to continue with a positive momentum. On the upside, however, it stumbled to 16,400 where it attracted some lucrative bookings,” Gaurav said.

The internal structure of the recent upswing shows that today’s negative close is a short break and short-term pullbacks are still intact, he said.

Ratnaparkhi was of the opinion that the index is expected to witness new buying support around 16200. “Thus, this small degree of decline can be taken as a new buying opportunity from a short-term business perspective. On the upside, the short-term target is pegged at 16500. The 16000 level will serve as a support for the short term,” he suggested.

Rupak Dey, senior technical analyst at LKP Securities, said the Nifty found resistance at significant resistance at 16400 and went down, closing with a slight loss.

On the daily chart, the index is below the short-term moving average, he said.

“The daily RSI is in a bullish crossover. The trend is likely to be bearish in the near term. Resistance at the upper end is set at 16400. At the lower end, support is visible at 16000,” added Rupak Dey.

FIIs, meanwhile, continued their sell-off as they sold equity worth Rs 2,192.44 crore in the Indian market on Tuesday. Also, they were net sellers so far in the month with sales figures of Rs 36,682.40 as of May 17.

Reserve Bank Governor Shaktikant Das has asked banks to be vigilant about ongoing geopolitical developments and take measures to mitigate their balance sheets, including raising capital to minimize potential impact.

The Reserve Bank of India (RBI) said in a statement that the governor and other RBI officials met on Wednesday and the day before with MDs and CEOs of selected public and sector banks.

In his introductory remarks, Das referred to the “key role” played by banks in supporting the economy throughout the epidemic.

He added that the banking sector has remained resilient and has continued to improve despite facing various headaches.

“He advised banks to be aware of the recent geopolitical developments and to take proactive mitigation measures, including raising capital, to ensure that their balance sheets have a potential impact,” the RBI said.

Slave banks have been asked to pay special attention to further improving their grievance redressal system and continue to provide necessary assistance in reviving ongoing economic activity.

Among other topics discussed were credit of tech, asset quality, collection efficiency, consumer grievance redressal, setting up of digital banking units, resilience of IT infrastructure and cyber security protection in banks.

The meeting was attended by Deputy Governor, MK Jain and M Rajeshwar Rao.

The ongoing Russia-Ukraine war has affected the global supply chain, leading to rising commodity prices. Central banks, including the RBI, have taken a number of steps to curb rising inflation.

Kotak Alternate Assets, managed by Kotak Investment Advisors Limited (KIAL), said on Wednesday that it would raise up to Rs 2,000 crore from investors to lend to mid-market growth-based companies.

The Kotak Private Credit Fund will be an alternative investment fund of Rs 1,000 crore Division II and will have a greenshoe option to raise another Rs 1,000 crore.

The platform will focus on the performing credit space and lend to growth-oriented companies with established business models in the mid-market to secure the return of middle-aged adolescents, a statement said.

Srinivasan, managing director of KIAL, said the fundraising efforts are in line with the developing personal credit ecosystem and will help KIAL to make its mark in the field of credit investment by investing in secure credit.

KIAL has hired Neeraj Kariya from Buyout Major KKR to lead the personal credit practice.
“Neeraj will be a senior member of the KIAL Alternate Asset Management team. He will add strength and depth to our platform for future planning and scale building,” said Srinivasan.

KIAL, a part of Kotak Mahindra Bank, focuses on alternative assets business. KIAL was established in early 2005 and has raised / managed / advised over USD 5.1 billion in various asset classes, including private equity funds, real estate funds, infrastructure funds and special circumstances funds.

Q4 Results 2022: Listed companies Galaxy Surfactants and Indian Overseas Bank (IOB) today announced their March quarter results. The former reported a net profit of Rs 98 crore but the latter earned a net profit of Rs 552 crore. The Galaxy Surfactants PAT jumped 25 percent while the IOB jumped 58 percent. Here are the main highlights of the results:

Galaxy Surfactants Q4 Result 2022: Profit increased by 25% to Rs 98 crore

Specialty care product maker Galaxy Surfactants Limited (GSL) on Wednesday posted a 25 per cent jump in net profit to Rs 98.40 crore for the fourth quarter ended March 2022 on strong earnings.

According to a regulatory filing, the company had posted a net profit of Rs 78.68 crore in the same quarter last fiscal.

Total income increased to Rs 1,054.13 crore in January-March 2021-22 from Rs 786.10 crore in the previous year.

“This has been a strong quarter for us. Amid global uncertainty, Galaxy has reported its highest quarterly profit,” said managing director U Shekhar.

Although overall performance in the last fiscal year was muted, the company ended the year on a strong note, he said.

According to the filing, the company had a net profit of Rs 262.78 crore in 2021-22, down from Rs 302.14 crore in the previous fiscal.

Total income, however, was Rs 3,698.22 crore more than Rs 2,94.92 crore in 2020-21.

“If FY22 is about managing supply-side risks, we believe FY23 will handle both; supply-side as well as ‘demand-side’ risks.

The company is seeing the first signs of declining demand and down-trading in some parts of India. The deteriorating supply situation due to the Russia-Ukraine war and the lockdown in China will exacerbate it, he said.

“In this context, we launch FY23 on a cautionary note,” he said.

Shares of Galaxy Surfactants rose nearly 4 percent on the NSE on Wednesday.

Watch G Business Live TV streaming below:

Indian Overseas Bank Q4 Results 2022: Net Profit Rises 58% to Rs 552 Crore

State-owned Indian Overseas Bank (IOB) jumped nearly 58 per cent to a net profit of Rs 552 crore for the quarter ended March 2022 on Wednesday, mainly due to lower provisions for bad loans.

The bank had posted a net profit of Rs 350 crore a year ago.

However, according to a regulatory filing, the bank’s total revenue fell to Rs 5,719 crore in the last March quarter from Rs 6,074 crore in the same period a year ago.

The bank’s interest income rose 4 per cent to Rs 4,215 crore in the fourth quarter ended March.

Asset quality has improved as gross non-performing assets (NPAs) fell to 9.82 percent of total growth as of March 31, 2022 from 11.69 percent a year earlier. At the end of December 2021, it was 10.40 percent.

Net NPAs or bad debts have come down from 3.58 per cent to 2.65 per cent on an annual basis. In turn, it was slightly higher than 2.63 percent at the end of December 2021.

Bad debt and non-performing loans for the March 2022 quarter fell to Rs 1,014 crore from Rs 1,380 crore in the year-ago period.

On a year-on-year basis, the bank has increased its net profit by 106 per cent to Rs 1,710 crore in 2021-22. In 2020-21 it was Rs 831 crore.

However, the annual revenue fell to Rs 21,633 crore from Rs 22,525 crore in the previous fiscal year ending March 2021.

Shares of Indian Overseas Bank rose 4.12 per cent to close at Rs 17.70 on the BSE.

Input from PTI

Britain’s inflation rate hit a 40-year high last month as Russia’s war in Ukraine pushed food and fuel prices higher.

Consumer price inflation accelerated to 9% in the 12 months to April, from 7% the previous month, the Office for National Statistics reported Wednesday. According to the agency’s statistical modeling, this is the highest rate since 1982, when inflation reached 11%.

The figures will increase pressure on governments to alleviate the cost of living that economists predict will be the biggest decline in living standards since the 1950s.

Millions of households across the UK have been hit by a 54% jump in gas and electricity bills in the past month after regulators increased fuel price caps to reflect rising wholesale prices. Russia’s aggression in Ukraine has put further pressure on food and fuel prices.

The government is planning to cut income taxes and increase subsidies for low-income people struggling to pay their fuel bills, British media reported on Wednesday. It is also considering imposing a tax on the uncomfortable profits of energy companies, which have benefited from higher oil and gas prices.

With global inflation rising, the United States reported a nearly four-decade high of 8.3% last month. The 19 countries that use the euro have seen months of inflation, but the European Union’s statistics agency on Wednesday revised its preliminary 7.5% figure for April to 7.4%. This keeps the annual rate stable with March, Eurostat said.

Central banks around the world have moved to deal with rising consumer prices by raising interest rates. The US Federal Reserve raised its key rate this month for the first time since 2000 and suggested it would continue, as the Bank of England became more aggressive.

The bank has raised its key rate four times since December, reaching a 13-year high this month.

Scientists at the University of Oxford and the University of Southampton in the UK have found that hormone replacement therapy can reduce mortality from viral diseases within six months of the recorded diagnosis of Covid-19. The results of the study were published in the journal Family Practice. While conducting the study, researchers examined the relationship between hormone replacement therapy or combined oral contraceptive use and the risk of death in women with COVID-19.

Scientists have tested a combination of oral contraceptives, which contain estrogen, because some recent observations show that women who take oral contraceptives have a lower risk of developing COVID-19. The team used an earlier team with medical records from the Oxford-Royal College of General Practitioners Research and Surveillance Centre’s primary care database. In addition, the team identified a team of 1,863,478 women over the age of 18 from 465 general practices in England.

According to scientists, hormone replacement therapy Covid-19 was associated with a 22 percent reduction in mortality. This suggests that estrogen may have a protective effect against the exacerbation of COVID-19.

“This study supports the theory that estrogen may provide some protection against severe COVID-19. We hope this study can reassure patients and physicians that there is no indication that the epidemic will stop hormone replacement therapy, “said Christopher Wilcox, one of the authors of the study.

Researchers have also found that although men and women are equally susceptible to the SARS-CoV-2 virus, men are more prone to more serious infections. Meanwhile, previous studies have also shown that women have faster and greater immunity to viral infections.

In addition, researchers have observed similar data in previous epidemics, including outbreaks of severe acute respiratory syndrome corona virus (SARS-CoV) and Middle Eastern respiratory syndrome corona virus (MERS-CoV).

“The reason for this gender difference is uncertain. Limited recent observational data suggest that estrogen may reduce the severity of COVID-19 disease, ”the study authors noted.

In an exclusive interview with Anil Singhvi, Managing Editor, G Business, Patanjali Ayurveda founder Yoga Guru Swami Ramdev confirmed that Patanjali Ayurveda, which will run herbal cosmetics and medicine business, will be a non-food company. He said the company would also be listed on the domestic exchange.

He said the company would launch an initial public offering (IPO) in the near future.

Yoga guru Ruchi Soya Industries has also decoded the reason behind renaming Patanjali Foods and revealed that they will soon launch a public offer of Patanjali Ayurveda.

According to Swami Ramdev, Patanjali’s brand value is much higher than Ruchi Soya. He added that more than eight divisions of the food business would be shifted to Ruchi Sowa through a recessionary sale of around Rs 690 crore.

What? # Patanjali What is a megaplan?# Taste What’s the next plan?
Husband Ramdev’s ‘business mantra’
Talk about a ‘self-reliant India’ plan

See with husband Ramdev # Exclusive Discussion …Yogisiramdev
Anil Singhvi_ @ Ach_Balakrishna PypAyurved https://t.co/t3FHuYtvap

– Zee Business (ZeeBusiness) May 18, 2022

In the last two years, Ramdev said, “We have not only turnaround Ruchi Soa, but also doubled Ruchi Soa’s overall turnover, increasing its profits 2.5-3 times.” This was largely due to good corporate governance, strong distribution and brand value among others, he said.

Citing the DRHP / RHP paper as a promise, Ramdev added, “We are looking for investor benefits as promised and we want to move our consumer and retail base forward.” He said this when Anil Singhvi wanted to know the reason for shifting business at such a low price.

He confirmed that Patanjali Ayurveda, which will run the herbal cosmetics and mediation business, will be the only non-food company and is considering launching an initial public offering (IPO) soon.

Regarding debt reduction, Ramdev said, “Ruchi Soya has already been made a debt-free company, but we will make Patanjali Ayurveda a debt-free company by the end of this year.”

“As per the rules, we have to dilute more than 6 per cent stake in Ruchi Soya Fund and the collected Patanjali Ayurveda will be used for debt relief,” he explained.

“Patanjali will play a key role in promoting Prime Minister Narendra Modi’s self-reliant India,” Ramdev said, referring to two business associations in the food and herbal cosmetics sector. The company is working in the same direction and will take Patanjali Foods (Ruchi Soya) to a new level. ”

“We are planning a turnover of around Rs 5,200 crore and EBITDA is moving ahead with new entity Patanjali Foods for around Rs 800 crore,” he said.

Ruchi Soya Industries announced the name change at a board meeting on Wednesday, May 18. According to the board, Patanjali Foods will be renamed Ruchi Soya Industries Limited.

The board has approved a business transfer agreement with Patanjali Ayurveda Limited to acquire food retail business, which includes manufacturing, packaging, labeling and retail of some food products, Ruchi said in a regulatory filing on Wednesday.

Sun Pharma announced on Wednesday that it plans to launch a drug to lower low-density lipoprotein (LDL) cholesterol.

Mumbai-based drug major says a wholly-owned subsidiary plans to launch first-class oral medication, bempedoic acid, in India to lower LDL cholesterol.

The company will launch the drug under the brand name Brilo.

The drug is a first-class drug that has a new mode of action compared to the currently available lipid-lowering agents.

It is indicated for people who have a hereditary genetic disorder that causes high cholesterol levels or established heart disease where cholesterol levels are high despite lifestyle changes and the use of the most tolerable dose of statins.

” Sun Pharma is a leader in cardiovascular disease and a pioneer in lipid-lowering therapy in India. In line with our commitment to launching innovative products, we are launching this first-class oral drug Brillo, “Sun Pharma CEO – India Business Kirti Gankar said in a statement.

The product is a fancy treatment option that will help patients with heart disease manage high LDL cholesterol, a condition that is growing at an alarming rate, he added.

The incidence of heart disease in India is 272 per 100,000 population, more than 235 per 100,000 population worldwide on average.

Some patients with elevated cholesterol levels may respond inadequately to statins. There is also a set of patients who are intolerant to statins. Bempedoic acid may be an effective treatment option for such patients.

The Brillo launch will meet this significant unmet demand in India, the company said.

As per IMS MAT January 2022, the statin market size in India is around Rs 4,300 crore.

State-owned Indian Overseas Bank (IOB) jumped nearly 58 per cent to a net profit of Rs 552 crore for the quarter ended March 2022 on Wednesday, mainly due to lower provisions for bad loans.

The bank had posted a net profit of Rs 350 crore a year ago.

However, according to a regulatory filing, the bank’s total revenue fell to Rs 5,719 crore in the last March quarter from Rs 6,074 crore in the same period a year ago.

The bank’s interest income rose 4 per cent to Rs 4,215 crore in the fourth quarter ended March.

Asset quality has improved as gross non-performing assets (NPAs) fell to 9.82 percent of total growth as of March 31, 2022 from 11.69 percent a year earlier. At the end of December 2021, it was 10.40 percent.

Net NPAs or bad debts have come down from 3.58 per cent to 2.65 per cent on an annual basis. In turn, it was slightly higher than 2.63 percent at the end of December 2021.

Bad debt and non-performing loans for the March 2022 quarter fell to Rs 1,014 crore from Rs 1,380 crore in the year-ago period.

On a year-on-year basis, the bank has increased its net profit by 106 per cent to Rs 1,710 crore in 2021-22. In 2020-21 it was Rs 831 crore.

However, the annual revenue fell to Rs 21,633 crore from Rs 22,525 crore in the previous fiscal year ending March 2021.
The bank’s stock rose 4.12 per cent to close at Rs 17.70 on the BSE.